Terms: = Pancreatic cancer AND AFP, AFPD, FETA, HPAFP AND Diagnosis
110 results:
1. Diagnostic performance of PIVKA-II in identifying recurrent hepatocellular carcinoma following curative resection: a retrospective cohort study.
Zhu W; Wang W; Zheng W; Chen X; Wang X; Xie J; Jiang S; Chen H; Zhu S; Xue P; Jiang X; Li H; Wang G
Sci Rep; 2024 Apr; 14(1):8416. PubMed ID: 38600210
[TBL] [Abstract] [Full Text] [Related]
2. Protein kinase C delta enhances the diagnostic performance of hepatocellular carcinoma.
Nakagawa C; Oikawa T; Yamada K; Tsubota A; Saeki C; Katagiri K; Tago N; Kamioka H; Ueda K; Haruki K; Furukawa K; Nakano M; Torisu Y; Ikegami T; Yoshida K; Saruta M
Biomarkers; 2024 Mar; 29(2):55-67. PubMed ID: 38361436
[TBL] [Abstract] [Full Text] [Related]
3. Transcriptomic Signature of 3D Hierarchical Porous Chip Enriched Exosomes for Early Detection and Progression Monitoring of Hepatocellular Carcinoma.
Yi K; Wang Y; Rong Y; Bao Y; Liang Y; Chen Y; Liu F; Zhang S; He Y; Liu W; Zhu C; Wu L; Peng J; Chen H; Huang W; Yuan Y; Xie M; Wang F
Adv Sci (Weinh); 2024 Apr; 11(14):e2305204. PubMed ID: 38327127
[TBL] [Abstract] [Full Text] [Related]
4. Proteomics-driven noninvasive screening of circulating serum protein panels for the early diagnosis of hepatocellular carcinoma.
Xing X; Cai L; Ouyang J; Wang F; Li Z; Liu M; Wang Y; Zhou Y; Hu E; Huang C; Wu L; Liu J; Liu X
Nat Commun; 2023 Dec; 14(1):8392. PubMed ID: 38110372
[TBL] [Abstract] [Full Text] [Related]
5. [Extragonadal germ cell tumor: A case report and review of the literature].
Li P; Wu D; Xu XF; Fu D; Jia RP; Ge JP
Zhonghua Nan Ke Xue; 2022 Nov; 28(11):1026-1030. PubMed ID: 37846120
[TBL] [Abstract] [Full Text] [Related]
6. Vertically-Ordered Mesoporous Silica Film Based Electrochemical Aptasensor for Highly Sensitive Detection of Alpha-Fetoprotein in Human Serum.
Zhang T; Yang L; Yan F; Wang K
Biosensors (Basel); 2023 Jun; 13(6):. PubMed ID: 37366993
[TBL] [Abstract] [Full Text] [Related]
7. Construction and validation of a survival prognostic model for stage III hepatocellular carcinoma: a real-world, multicenter clinical study.
Hao S; Luo R; Li W; Zhao R; Qi T; Wang Z; Li N; Liu M
BMC Gastroenterol; 2023 Jun; 23(1):207. PubMed ID: 37312022
[TBL] [Abstract] [Full Text] [Related]
8. Liquid biopsy using cell-free DNA in the early diagnosis of hepatocellular carcinoma.
Hu S; Liu Y; Yang Q; Chen L; Chai H; Xiao M; Qi C; Qiu W
Invest New Drugs; 2023 Jun; 41(3):532-538. PubMed ID: 37099161
[TBL] [Abstract] [Full Text] [Related]
9. A distinct microbiota signature precedes the clinical diagnosis of hepatocellular carcinoma.
Yang J; He Q; Lu F; Chen K; Ni Z; Wang H; Zhou C; Zhang Y; Chen B; Bo Z; Li J; Yu H; Wang Y; Chen G
Gut Microbes; 2023; 15(1):2201159. PubMed ID: 37089022
[TBL] [Abstract] [Full Text] [Related]
10. Comparison of diagnostic performance of afp, DCP and two diagnostic models in hepatocellular carcinoma: a retrospective study.
Chen Y; Yang X; Shao Y; Zhao H; Jiang J; Huang P; Lu Y; Xuan Z
Ann Hepatol; 2023; 28(4):101099. PubMed ID: 37030571
[TBL] [Abstract] [Full Text] [Related]
11. The Potential Utility of Circulating Oncofetal H19 Derived miR-675 Expression versus Tissue lncRNA-H19 Expression in diagnosis and Prognosis of HCC in Egyptian Patients.
Abdelsattar S; Sweed D; Kamel HFM; Kasemy ZA; Gameel AM; Elzohry H; Ameen O; Elgizawy EI; Sallam A; Mosbeh A; Abdallah MS; Khalil FO; Al-Amodi HS; El-Hefnway SM
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671388
[TBL] [Abstract] [Full Text] [Related]
12. Diagnostic performance of circulating tumor DNA as a minimally invasive biomarker for hepatocellular carcinoma: a systematic review and meta-analysis.
Li JJ; Lv Y; Ji H
PeerJ; 2022; 10():e14303. PubMed ID: 36348665
[TBL] [Abstract] [Full Text] [Related]
13. Preoperative contrast-enhanced computed tomography-based radiomics model for overall survival prediction in hepatocellular carcinoma.
Deng PZ; Zhao BG; Huang XH; Xu TF; Chen ZJ; Wei QF; Liu XY; Guo YQ; Yuan SG; Liao WJ
World J Gastroenterol; 2022 Aug; 28(31):4376-4389. PubMed ID: 36159012
[TBL] [Abstract] [Full Text] [Related]
14. Prothrombin induced by vitamin K Absence-II versus alpha-fetoprotein in detection of both resectable hepatocellular carcinoma and early recurrence after curative liver resection: A retrospective cohort study.
Wang MD; Sun LY; Qian GJ; Li C; Gu LH; Yao LQ; Diao YK; Pawlik TM; Lau WY; Huang DS; Shen F; Yang T
Int J Surg; 2022 Sep; 105():106843. PubMed ID: 35995351
[TBL] [Abstract] [Full Text] [Related]
15. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract] [Full Text] [Related]
16. Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma.
Shi L; Qu Z; Yang Y; Zhang Y; Sun D
Comput Math Methods Med; 2022; 2022():8195512. PubMed ID: 35356664
[TBL] [Abstract] [Full Text] [Related]
17. The Landscape Of Alpha Fetoprotein In Hepatocellular Carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract] [Full Text] [Related]
18. Pitfalls in the diagnosis of yolk sac tumor: Lessons from a clinical trial.
Yang A; Patterson A; Pavlock T; Chen KS; Gagan J; Hatley ME; Frazier AL; Amatruda JF; Laetsch TW; Rakheja D
Pediatr Blood Cancer; 2022 Feb; 69(2):e29451. PubMed ID: 34866303
[TBL] [Abstract] [Full Text] [Related]
19. Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma.
Wang F; Liu H; Bai Y; Li H; Wang Z; Xu X
J Clin Lab Anal; 2021 Nov; 35(11):e24025. PubMed ID: 34569662
[TBL] [Abstract] [Full Text] [Related]
20. Performance evaluation of CA242 by flow fluorescence assay.
Hou Y; Chen Y; Sun J; Geng J; Jin H; Zhang Z
Medicine (Baltimore); 2021 Apr; 100(15):e25301. PubMed ID: 33847629
[TBL] [Abstract] [Full Text] [Related]
[Next]
